|Articles|March 1, 2010

BioPharm International

  • BioPharm International-03-01-2010
  • Volume 23
  • Issue 3

BioPharm International, March 2010 Issue (PDF)

Best Practices for Characterizing Formulation Design
To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

almost 16 years ago

India's Future as a Biologics Manufacturing Hub

almost 16 years ago

Downstream Processing: Promising Technologies are on the Horizon

almost 16 years ago

Corrective and Preventative Action Programs: A Mechanism of Control

almost 16 years ago

Characterizing the Formulation Design Space

almost 16 years ago

FDA Seeks More Timely Drug Information Electronically

almost 16 years ago

The Role of Process History in Establishing Clear Technology Transfer Criteria

almost 16 years ago

Quality Considerations for Peptide Manufacturing Processes

almost 16 years ago

Lessons from the War on Terrorism

almost 16 years ago

Mathematical Programming for the Design and Analysis of a Biologics Facility-Part 2

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!